The injury lawyers at Fetterman & Associates P.A. are evaluating claims from people who were diagnosed with cancer after taking Belviq, Belviq XR, or another brand of lorcaserin.
Belviq (generic name lorcaserin) is a prescription weight-loss drug made by Eisai Inc. to help people experiencing weight-related health issues reduce or curb their hunger. However, a U.S. Food and Drug Administration (FDA) safety trial concluded that using this drug could increase the risk of different types of cancer, including pancreatic, lung, and colorectal cancer. The FDA issued a full recall of Belviq in February 2020.
Weight-loss drugs do not have a history of safety. Belviq continues that poor record. In a five-year, double-blind study of 12,000 patients, those taking Belviq were more likely to be diagnosed with cancer than those taking a placebo (sugar pill). The FDA stated, “A range of cancer types was reported, with several different types of cancers occurring more frequently in the lorcaserin group,” including:
This is a drug that should never have been on the market, and Eisai Inc need to be held accountable.
If you or a loved one took Belviq and were diagnosed with cancer, cal our office today for a FREE consultation. There is never a fee until we recover compensation for you. Call and ask questions today.
Yes. In February 2020, the FDA requested that manufacturer Eisai pull all Belviq and Belviq XR products from the market. Eisai has complied with the request.
Anyone taking Belviq should stop and talk to a healthcare professional about possible safer alternatives.
If you took Belviq or its generic equivalent and were diagnosed with cancer, you should consider taking legal action against the drug’s manufacturer. If you meet these criteria, you may have a case:
Every case is unique, but people who successfully file drug or medical device lawsuits can recover compensation for some or all of the following damages:
Contact us today at 5618452510
